Executive Retention AgreementExecutive Retention Agreement • February 7th, 2020 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
Contract Type FiledFebruary 7th, 2020 Company Industry JurisdictionTHIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and ________________________ (the “Executive”), is made as of ________________________, (the “Effective Date”).